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 Review Article 
Solid dispersion technology, a contemporary overview on a well-established technique 
 
tcartsbA 
Solubility is a significant physicochemical parameter thataffects the absorption, 
bioavailability and therapeutic effectiveness of any drug. Formulation development would 
fail if drug has a poor aqueous solubility. This review article highlights recent advances in 
solid dispersiontechnology and its applications in contemporary pharmaceutical research.   
 
Introduction 
Solubility is a significant physicochemical parameter that affects all characteristics of a drug 
substance
1
. According to literature, about 70% of newly-discovered drug substances have 
aqueous solubility problems
2
. This represents a great challenge to pharmaceutical industry as 
it leads to poor absorption, poor bioavailability and probably,failure of treatment
1
. Over 
decades, scientists have developed several approaches to overcome solubility problems 
including the use of surfactants
3
, cosolvents
3
, inclusion complexes
4
, self-emulsifying 
systems
5
, prodrugs
6
 and micro-environmental buffering systems
7
. Solid dispersion 
technology has become one of the well-established techniques for solubilization of poorly-
soluble drugs
8
. It has been extensively used in pharmaceutical literature for solubilization of 
massive number of hydrophobic drugs. Although the technique seems to be "a part of the 
past", literature tells us that it is still be used and developed to suit current needs of 
pharmaceutical industry. This review article highlights recent advancesin solid dispersion 
technology and its applications in contemporary pharmaceutical research.   
History and definitions of solid dispersiontechnology: 
In 1961, Sekiguchi and Obi
9
 first used solid dispersions technology to increase the dissolution 
and oral absorption of poorly water-soluble drugs. They assumed the formation of an eutectic 
mixture of a poorly water-soluble drug with a physiologically inert,hydrophilic carrier. In 
1966, Mayersohn and Gibaldi
10
 described solid dispersion as a "solid-state dispersions" or   
"a solid solution". In 1971, Chiou and Riegelman
11
 defined solid dispersion as ―the dispersion 
of one or more active ingredients in an inert carrier matrix at solid-state prepared by the 
melting, solvent or melting-solvent method‖. In 1985, Corrigan12 defined the term as            
―a product formed by converting a fluid drug-carrier combination to the solid state‖.  
Recently, Dhirendra et al.
13
 defined solid dispersion as ―a group of solidproducts consisting 
of at least two different components, generally a hydrophilic matrix and a hydrophobic drug. 
The matrix can be either crystalline or amorphous. The drug can be dispersed molecularly, in 
amorphous particles (clusters) or in crystalline particles". 
Classification of solid dispersion systems: 
In 2007, Chokshi et al.
14
 classified solid dispersion systems according to thecrystalline status 
of drug within the system.  If the drug is converted to amorphous form and forms one phase 
system with polymer, it can be classified as a "solid solution", whereas if the drug exists as 
microcrystalline dispersion, i.e., forms two-phase system, it is generally referred to as a "solid 
dispersion". In 2015, Meng et al.
15
 extended the classification according to thecrystalline 
status of both drug and carrier. They classified the systems as the following: 
i. Class C–C: Crystalline active pharmaceutical ingredient (API) dispersed in crystalline 
carrier. 
ii. Class C–A: crystalline API dispersed in amorphous carrier. 
iii. Class A–C: Amorphous API dispersed in crystalline carrier. 
iv. Class A–A: Amorphous API dispersed in amorphous carrier. 
v. Class M–C: API molecularly dispersed in crystalline carrier. 
 vi. Class M–A: API molecularly dispersed in amorphous carrier. 
Advantages of solid dispersion technology:
 16 
The major advantage of solid dispersions is that they improve the solubilityof poorly water 
soluble drugs in pharmaceutical dosage forms which results in rapid dissolution rates and 
improved bioavailability of drugs. Moreover, the approach also offers others advantages 
including: 
i. Rapid dispersion into water which is beneficial in the formulation offast-dissolving 
tablets that can be used as an alternative to parenteral therapy enabling patient for 
self-medication even without the aid of water. 
ii. High degree of particle size reduction which is advantageous over traditional grinding 
in that it is suitable for waxy substances, produces no dust and there is nodanger for 
explosion.  
iii. Ability to produce a controlled pattern of drug release using the suitable retarding 
excipients like cellulose derivatives. 
iv. Ability to formulate liquid drugs into solid dosage forms through their mixing with 
molten carriers followed by rapid cooling and pulverization. This method was 
successful with several liquid drugs including methyl salicylate and clofibrate. 
v. Solid dispersions can result in precipitation of drugs in amorphous statewith higher 
solubility and dissolution rate than the more stable crystalline state. 
Disadvantages of solid dispersion technology: 
i. Most of the polymers used in solid dispersions can absorb moisture, which may 
results in phase separation, crystal growth or conversionfrom the amorphous state to 
the crystalline state or from a metastable crystalline form to a more stable structure 
during storage. This may results in decreased solubility and dissolution rate.
17
 
ii. Poor scale-up for the purposes of manufacturing.17 
iii. Stability problems: Younis18 reported the dissolution rate lowering of solid 
dispersions on aging owing to recrystallization of the amorphous drug in system 
and/or polymorphic transitions that are frequently associatedwith the aged solid 
dispersions. 
Common materials used in preparation of solid dispersions: 
There are several materials that can be used as hydrophilic carriers in preparation of solid 
dispersions. Some examples are briefly discussedbelow. 
Polyethylene glycols (PEGs) 
Polyethylene glycols (PEGs) are polymers of ethylene oxide, with a molecularweight falling 
in the range 200-300,000. For the manufacture of solid dispersions, PEGs with a molecular 
weight 1500-20,000 are usually employed. PEGs have many advantages including high 
aqueous solubility, low cost, low toxicity and low melting points (below 65 °C) makingthem 
suitable carriers for preparation of solid dispersions by melting method.
19 
Polyvinylpyrrolidone (PVP) 
Polymerization of vinylpyrrolidone leads to polymers of molecular weight ranging from 2500 
to 300,000. They are inert, safe, highly water-soluble and soluble in a wide variety of 
solvents including alcohol. The main disadvantages of PVPs are hygroscopicity and high 
melting points (above 265 °C) making them more suitable for preparation ofsolid dispersions 
by solvent-based methods instead of heating-based methods.
20 
Urea 
It is the end product of protein metabolism and can also be synthesized by chemical reactions. 
It is highly water-soluble, soluble in many common organic solvents andhas a moderate 
melting point (132-135 °C) making it suitable for preparation of solid dispersions bydifferent 
methods.
21 
 Sugars 
Although sugars have high aqueous solubility, they have many drawbacks regarding their use 
as carriers in solid dispersions. Most of them have high melting points making them 
problematic in the preparation of solid dispersions by heating methods. Theyare also poorly-
soluble in most organic solvents creating problem in preparation of solid dispersions by 
solvent methods. Despite these draw backs, mannitol and sorbitol were reported to be used as 
carriers for manydrugs.
22 
Poloxamers 
Poloxamers are poly (oxyethylene)-poly (oxypropylene) copolymers, with trade names as 
Supronic, Pluronic or Tetronic. They have been introduced in 1950 and were since then very 
famously used in diverse pharmaceutical applications. Theyare composed of two hydrophilic 
chains of polyethylene oxide (PEO) sandwiching one hydrophobic polypropylene oxide chain 
(PPO). They are classified according to the proportions of hydrophilic and hydrophobic 
chains including poloxamer 124, 188, 237, 338 and 407 as the most common types. They are 
used as gelling agents, surfactants, stabilizers and hydrophilic carriers. They are soluble in 
different solvents and have low melting points (52-57 °C) makingthem suitable carriers for 
preparation of solid dispersions by different methods.
23 
Methods of preparation of solid dispersions: 
There are several methods used to prepare solid dispersions which have been developed from 
simple manual procedures to advanced techniques requiring special equipment to fulfill the 
needs of modern pharmaceutical industry. Some of these varioustechniques are briefly 
discussed below. 
1. Co-melting method:
 24 
This method involves the preparation of physical mixture of a drug and a water-soluble 
carrier and heating it directly till melting. The molten mixture is then solidified rapidly in an 
ice-bath under vigorous stirring. The final solid mass is crushed, pulverized and sieved. The 
modification in the method can be done by pouring the homogenous melt in the form of a 
thin layer onto a ferrite plate or a stainless steel plate and cooled by flowing air or water on 
the opposite side of the plate. In addition, a super-saturation of a solute ordrug in a system 
can often be obtained by quenching the melt rapidly from a high temperature. Under such 
conditions, the solute molecule is arrested in the solvent matrix by the instantaneous 
solidification process. The quenching technique gives a much finer dispersion of crystallites 
when used for simple eutectic mixtures. Advantage of co-melting method is that it is 
economic and solventless process, however this method is not suitable for the drug or carrier 
which is unstable at fusion temperature or evaporates at higher temperature. Some of the 
means to overcome these problems could be by heating the physical mixture in a sealed 
container or melting it under vacuum or in presence of inert gas likenitrogen to prevent 
oxidative degradation of drug or carrier.  
2. Fusion method: 
25 
It is a modification of co-melting method. The carrier is placed in a porcelain dish and heated 
till melting over steam bath. The accurately weighed amount of drug isdispersed into molten 
carrier gradually using a glass rod. After complete dispersion of drug within carrier, the dish 
is removed from steam bath and left aside to cool at room temperature till solidification of its 
contents. Then, the solid dispersion formed is pulverized and sieved. Thismethod is useful in 
reducing thermal decomposition of drugs. 
3. Solvent evaporation method: 
26 
Both drug and carrier are dissolved in a common volatile solvent which is then, removed 
under vacuum. The formed solid dispersion is pulverized and sieved. 
4. Kneading technique: 
27 
 In this method, carrier is permeated with water and transformed to paste. Drug is then added 
and kneaded for particular time. The kneaded mixture is then dried and passed through sieve 
if necessary. This method is suitable for thermolabile drugs but, it is notsuitable for drugs 
sensitive to moisture. 
5. Co-precipitation method: 
28 
Required amount of drug is added to the solution of carrier. The system is kept under 
magnetic agitation and protected from the light. The formed precipitate isseparated by 
vacuum filtration and dried at room temperature.
 
6. Co-grinding method: 
29 
Physical mixture of drug and carrier is mixed for some time employing a blender at a 
particular speed. The mixture is then charged into the chamber of a vibration ball mill. The 
powder mixture is pulverized. Then, the product is collected and kept at roomtemperature in a 
screw capped glass vial until use.  
7. Gel entrapment technique: 
30 
Hydroxyl propyl methyl cellulose (used as a carrier) is dissolved in organic solvent to form a 
clear and transparent gel. Then, the drug is dissolved in gel by sonication for few minutes. 
Organic solvent is evaporated under vacuum. Solid dispersions are reduced insize by mortar 
and pestle and sieved. 
8. Spray drying method: 
31 
Drug is dissolved in suitable solvent and the required amount of carrier is dissolved in water. 
Solutions are then mixed by sonication or other suitable method to produce a clear solution, 
which is then spray dried using a spray dryer to produce solid dispersion inform of fine, free-
flowing particles.  
9. Electrospinning method: 
32, 33 
Electrospinning is a process in which solid fibers are produced from a polymeric fluid stream 
solution or melt delivered through a millimeter- scale nozzle. This process involves the 
application of a strong electrostatic field over a conductive capillaryattached to a reservoir 
containing a polymer solution or melt and a conductive collection screen. Upon increasing 
the electrostatic field strength up to a critical value, charge species accumulated on the 
surface of a pendant drop destabilize the hemispherical shape into a conical shape (commonly 
known as Taylor cone). Beyond the critical value, a charged polymer jet is ejected from the 
apex of the cone and carried to the collection screen via the electrostatic force. This technique 
has potential for the preparation of nanofibres and controlling the release of biomedicines. As 
it is simple and cheap, this technique can be utilized for thepreparation of solid dispersions in 
future. 
10. Freeze-drying method: 
34 
This process consists of dissolving the drug and carrier in a common solvent, which is 
immersed in liquid nitrogen until it is fully frozen. Then, the frozen solution is further 
lyophilized. Although it is concluded in literature that this is a promising and suitable 
technique to incorporate drug substances in stabilizing matrices, the technique is poorly 
exploited for the preparation of solid dispersions due to economicalreasons. Advantages of 
freeze drying include that the drug is subjected to minimal thermal stress during the 
formation of the solid dispersion and the risk of phase separation is minimized. 
11. Supercritical fluid (SCF) method: 
35 
Supercritical fluid methods are mostly applied with carbon dioxide (CO2), which is used as 
either a solvent for drug and matrix or as an anti-solvent. This technique consists of 
dissolving the drug and the carrier in a common solvent that is introduced into a particle 
formation vessel through a nozzle, simultaneously with supercritical CO2 (the gas is heated 
beyond its critical temperature and pressure). When the solution is sprayed, the solvent is 
rapidly extracted by the SCF, resulting in the precipitation of soliddispersion particles on the 
 walls and bottom of the vessel. Advantages of this technique include reduction of particle 
size and residual solvent content as well as the high yield. 
12. Direct capsule filling: 
36 
The technique includes direct filling of hard gelatin capsules with the liquid melt of drug and 
carrier. This molten dispersion forms a solid plug inside the capsule upon cooling to room 
temperature. Advantages include avoidance of grinding-induced changes in the crystallinity 
of drug, reduction of cross contamination and operator exposurein a dust-free environment, 
better fill weight and content uniformity.  
Characterization of solid dispersion systems: 
16 
There are several techniques used for characterization of solid dispersion systems including: 
i. Microscopic methods: Scanning Electron Microscopy (SEM) and Transmission 
Electron Microscopy (TEM). 
ii. Thermal methods: Differential Scanning Calorimetry (DSC) and Dissolution 
Calorimetry (DC). 
iii. Powder X-ray diffractometry (P-XRD). 
iv. Infrared Spectroscopy (IR). 
v. Powder flowability: angle of repose, compressibility.  
vi. Solubility studies. 
vii. In-vitro dissolution rate studies. 
viii. In-vivo studies: bioavailability, pharmacokinetics. 
ix. Stability Studies (effect of humidity, recrystallizationof amorphous drug). 
EXAMPLES OF DRUGS FORMULATED AS SOLID DISPERSIONS: 
A massive number of drugs have been formulated as solid dispersions in the pharmaceutical 
literature. Table (1) lists examples of them.  
Table (1): Examples of drugs formulated as solid dispersions. 
Drug name Use References 
Ampelopsin 
Anti-inflammatory, antimicrobial, 
relieving cough, antioxidant, 
antihypertensive, hepatoprotective and 
anticarcinogenic. 
4 
Albendazole 
Anthelmintic 24 
Carbamazepine 
Anti-epileptic 30 
Chlordiazepoxide 
Sedative and hypnotic 29 
Domperidone 
Anti-emetic 37, 38 
Indomethacin 
Anti-inflammatory 19 
Meloxicam 
Anti-inflammatory, analgesic 27 
Paracetamol 
Analgesic, antipyretic 25 
Sulfathiazole 
Antibacterial 9 
 Drug name Use References 
Tadalafil 
Treatment of erectile dysfunction 39 
Valsartan 
Antihypertensive 40 
Conclusion: 
Solid dispersion technology has been considered one of the well-established techniques in 
formulation of poorly-soluble drugs. Like every technique, it has several advantages and 
disadvantages that were discussed briefly in this article. Thereare several materials that can 
be used as carriers in formulation of solid dispersion ranging from natural sugars to synthetic 
polymers. There are several methods used in preparation of solid dispersions which vary from 
simple hand-made methods to advanced techniques requiring special equipment. Eventually, 
it can be concluded that solid dispersion technology stillcan be used and further developed to 
suit the needs of modern pharmaceutical industry. 
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